CIAM
STLN

Caitong International Asset Management’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Caitong International Asset Management’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.1K Sell
11,061
-22,219
-67% -$93.3K 0.01% 673
2026
Q1 		$102K Buy
33,280
+10,814
+48% +$33.2K 0.02% 569
2025
Q4 		$80K Buy
22,466
+19,190
+586% +$71.2K 0.02% 527
2025
Q3 		$11.4K Buy
+3,276
New +$11.2K 0.01% 970

Other funds holding STLN

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
IAAG
Innovative Asset Advisors Group Shelton, Connecticut $229M AUM

Caitong International Asset Management's STLN Position: Q2 2026 in Review

Caitong International Asset Management reduced its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 67% in Q2 2026, selling an estimated $93.3K and leaving 11,061 shares worth $60.1K. The position accounts for 0.01% of the portfolio, ranked #673.

Caitong International Asset Management first reported a position in STLN in Q3 2025 and has held it in 4 quarters since. The position peaked at $102K in Q1 2026. 29 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Caitong International Asset Management held 11,061 shares of Starling Oncology Institute, Inc. Common Stock worth $60.1K as of Q2 2026.
  • Caitong International Asset Management sold 22,219 Starling Oncology Institute, Inc. Common Stock shares in Q2 2026, an estimated $93.3K.
  • Starling Oncology Institute, Inc. Common Stock made up 0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #673 holding.
  • Caitong International Asset Management first reported a position in Starling Oncology Institute, Inc. Common Stock in Q3 2025 and has held it in 4 quarters since.
  • Caitong International Asset Management's Starling Oncology Institute, Inc. Common Stock position peaked at $102K in Q1 2026.
  • 29 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.